|Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: A multicentre retrospective cohort study|
The Lancet Infectious Diseases 16 (5), 565-575, 2016
|Comet assay and micronucleus test in circulating erythrocytes of Cyprinus carpio specimens exposed in situ to lake waters treated with disinfectants for potabilization|
A Buschini, A Martino, B Gustavino, M Monfrinotti, P Poli, C Rossi, ...
Mutation Research/Genetic Toxicology and Environmental Mutagenesis 557 (2 …, 2004
|HIV-1 genetic variability and clinical implications|
MM Santoro, CF Perno
ISRN microbiology 2013, 2013
|Antiretroviral therapy in prevention of HIV and TB: update on current research efforts.|
HG Granich R, Gupta S, Suthar AB, Smyth C, Hoos D, Vitoria M, Simao M ...
Curr HIV Res 9 (6), 446-69, 2011
|Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors|
V Svicher, T Sing, MM Santoro, F Forbici, F Rodrķguez-Barrios, A Bertoli, ...
Journal of virology 80 (14), 7186-7198, 2006
|Characterization and structural analysis of novel mutations in human immunodeficiency virus type 1 reverse transcriptase involved in the regulation of resistance to …|
F Ceccherini-Silberstein, V Svicher, T Sing, A Artese, MM Santoro, ...
Journal of virology 81 (20), 11507-11519, 2007
|Novel human immunodeficiency virus type 1 protease mutations potentially involved in resistance to protease inhibitors|
V Svicher, F Ceccherini-Silberstein, F Erba, M Santoro, C Gori, ...
Antimicrobial agents and chemotherapy 49 (5), 2015-2025, 2005
|High sequence conservation of human immunodeficiency virus type 1 reverse transcriptase under drug pressure despite the continuous appearance of mutations|
F Ceccherini-Silberstein, F Gago, M Santoro, C Gori, V Svicher, ...
Journal of virology 79 (16), 10718-10729, 2005
|Reliability and clinical relevance of the HIV-1 drug resistance test in patients with low viremia levels|
MM Santoro, L Fabeni, D Armenia, C Alteri, D Di Pinto, F Forbici, A Bertoli, ...
Clinical infectious diseases 58 (8), 1156-1164, 2014
|Population dynamics of HIV-1 subtype B in a cohort of men-having-sex-with-men in Rome, Italy|
G Zehender, E Ebranati, A Lai, MM Santoro, C Alteri, M Giuliani, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 55 (2), 156-160, 2010
|Drug resistance among drug-naive and first-line antiretroviral treatment-failing children in Cameroon|
J Fokam, R Salpini, MM Santoro, V Cento, CF Perno, V Colizzi, ...
The Pediatric infectious disease journal 30 (12), 1062-1068, 2011
|Different evolution of genotypic resistance profiles to emtricitabine versus lamivudine in tenofovir-containing regimens|
V Svicher, C Alteri, A Artese, F Forbici, MM Santoro, D Schols, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 55 (3), 336-344, 2010
|The HIV type 1 epidemic in Bulgaria involves multiple subtypes and is sustained by continuous viral inflow from West and East European countries|
M Salemi, MM Goodenow, S Montieri, T de Oliveira, MM Santoro, ...
AIDS research and human retroviruses 24 (6), 771-779, 2008
|Characterization of drug resistance mutations in naļve and ART‐treated patients infected with HIV‐1 in Yaounde, Cameroon|
L Ceccarelli, R Salpini, S Moudourou, V Cento, MM Santoro, J Fokam, ...
Journal of medical virology 84 (5), 721-727, 2012
|Specific Enfuvirtide-Associated Mutational Pathways in HIV-1 Gp41 Are Significantly Correlated With an Increase in CD4+ Cell Count, Despite Virological Failure|
S Valentina, S Aquaro, R D'Arrigo, A Artese, S Dimonte, S Alcaro, ...
The Journal of infectious diseases 197 (10), 1408-1418, 2008
|Impact of pre-therapy viral load on virological response to modern first-line HAART|
MM Santoro, D Armenia, C Alteri, P Flandre, A Calcagno, C Gori, L Fabeni, ...
International Medical Press 18 (7), 867-876, 2013
|Performance evaluation of an in-house human immunodeficiency virus type-1 protease-reverse transcriptase genotyping assay in Cameroon|
J Fokam, R Salpini, MM Santoro, V Cento, R D’Arrigo, C Gori, CF Perno, ...
Archives of virology 156 (7), 1235-1243, 2011
|Mutational correlates of virological failure in individuals receiving a WHO-recommended tenofovir-containing first-line regimen: an international collaboration|
SY Rhee, V Varghese, SP Holmes, GU Van Zyl, K Steegen, MA Boyd, ...
EBioMedicine 18, 225-235, 2017
|Lower prevalence of drug resistance mutations at first-line virological failure to first-line therapy with atripla vs. tenofovir+ emtricitabine/lamivudine+ efavirenz …|
JL Blanco, JSG Montaner, VC Marconi, MM Santoro, AE Campos-Loza, ...
Aids 28 (17), 2531-2539, 2014
|Non-B HIV type 1 subtypes among men who have sex with men in Rome, Italy|
M Giuliani, S Montieri, G Palamara, A Latini, C Alteri, CF Perno, ...
AIDS research and human retroviruses 25 (2), 157-164, 2009